Earth Science Tech, Inc. (OTC: ETST) reported financial and operational results for the third fiscal quarter ended December 31, 2025, highlighting significant growth in revenue and net income. The company achieved revenue of $8.4 million, a 14.1% increase year-over-year, with gross profit of $6.4 million reflecting a strong 76.3% margin. Net income surged to $910,000, representing a 341% increase from the prior-year period. Adjusted EBITDA totaled $1.2 million, underscoring improved operational performance.
The company's balance sheet strengthened during the quarter, with total assets increasing to $8.1 million. Earth Science Tech ended the quarter with $416,000 in cash and $773,000 in working capital, and importantly, no bank debt. Management attributed the robust results to continued operating leverage and ongoing expansion initiatives heading into calendar 2026.
During the first nine months of fiscal 2026, the company repurchased and retired 3.7 million shares, demonstrating a commitment to enhancing shareholder value. Earth Science Tech operates as a strategic holding company focused on value creation through acquisitions and operational optimization of its businesses. Its current operations include compounding pharmaceuticals, telemedicine, and real estate development through wholly owned subsidiaries such as RxCompoundStore.com, LLC, Peaks Curative, LLC, Avenvi, LLC, and others. The company also holds an 80% interest in MagneChef.
For further details on the financial results, the full press release can be accessed at https://ibn.fm/emIBm. Investors interested in the latest news and updates regarding ETST can visit the company’s newsroom at https://ibn.fm/ETST.
These results reflect Earth Science Tech's ability to capitalize on its diversified business model and operational efficiencies, positioning the company for continued growth. The significant improvement in net income and strong gross margins indicate effective cost management and revenue generation strategies. With no bank debt and a solid working capital position, the company appears well-positioned to pursue further expansion and value-enhancing initiatives.
